Terns Pharmaceuticals Inc (TERN) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $40.92
• Market Cap: $4.50B
• EPS: $-1.02
• 52-Week High: $48.26
• 52-Week Low: $1.86

Market Sentiment

Terns Pharmaceuticals Inc currently has a Bullish sentiment score of 0.30.

About Terns Pharmaceuticals Inc

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Foster City, California, focused on developing innovative small-molecule therapies aimed at treating nonalcoholic steatohepatitis (NASH) and other serious chronic liver diseases. With a robust pipeline of both single-agent and combination therapy candidates, Terns is at the forefront of addressing unmet medical needs in hepatology. The company’s commitment to advancing its clinical programs positions it as a ke...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Terns Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does TERN pay dividends?

Terns Pharmaceuticals Inc (TERN) does not currently pay a regular dividend.

What is TERN's market cap?

Terns Pharmaceuticals Inc (TERN) has a market capitalization of $4.50B with a current stock price of $40.92.